Today: 9 June 2026
Sidus Space (SIDU) stock surges 34% after new 7.4% stake filing hits SEC
2 January 2026
2 mins read

Sidus Space (SIDU) stock surges 34% after new 7.4% stake filing hits SEC

NEW YORK, Jan 2, 2026, 15:50 ET — Regular session

  • SIDU was up about 34% at $4.20, trading near the session high on heavy volume.
  • A new Schedule 13G showed CVI Investments and Heights Capital Management reporting a 7.4% stake.
  • Traders are weighing fresh ownership disclosures against dilution risk after a late-December share sale.

Shares of Sidus Space Inc (SIDU) jumped about 34% on Friday, putting the Nasdaq Capital Market-listed stock at $4.20 in afternoon trade. The session range ran from $3.39 to $4.44 with volume above 132 million shares, market data showed.

The move comes as traders scan a newly filed Schedule 13G — an SEC form used to disclose large passive stakes — showing a 7.4% position in the space and defense technology company.

Why it matters now: the ownership update follows a late-December equity financing that increased share supply. In small-cap names, fresh disclosures and new issuance can magnify day-to-day swings.

A filing dated Dec. 31 showed CVI Investments Inc. and Heights Capital Management Inc. reported beneficial ownership of 4 million Sidus shares, or 7.4% of the class. The form listed Dec. 22 as the event date triggering the disclosure and said Heights is the investment manager to CVI.

Schedule 13G is typically used by investors who say they are not seeking to influence or change control of the issuer; it differs from Schedule 13D, which is associated with activist intentions.

In a Dec. 26 Form 8-K, Sidus said it agreed to sell 10.8 million shares at $1.50 each in a registered direct offering, for gross proceeds of about $16.2 million. The company said the deal closed on Dec. 29 and that it planned to use proceeds for sales and marketing, operational costs, product development, manufacturing expansion and working capital. Sidus also said it would issue ThinkEquity warrants to buy up to 540,000 shares at $1.875 per share, exercisable immediately for five years.

Registered direct offerings use an effective SEC registration statement so the issued shares are registered for resale, unlike private placements. In a best-efforts deal, the agent markets the shares but does not guarantee a set amount will be sold.

For traders, the financing matters because new shares and warrants can add to dilution — the reduction in existing holders’ ownership percentage when more shares are issued.

Sidus has also pointed to defense work as a growth lever. In December it said it was one of the awardees under the Missile Defense Agency’s SHIELD indefinite-delivery/indefinite-quantity contract vehicle, which the company said carries a $151 billion ceiling; CEO Carol Craig said, “This milestone reflects our ability to deliver integrated solutions across multiple domains.” Sidus Space, Inc.

An IDIQ contract sets broad terms and a maximum value but does not guarantee revenue; task orders are competed and awarded over time. Investors will watch for any task-order wins or backlog updates tied to that program.

Sidus has no upcoming events listed on its investor calendar, leaving traders focused on additional SEC filings and any further capital-raising moves.

In the near term, traders are watching whether SIDU can hold above $4 and whether it revisits the $3.14 prior close as support. The session high near $4.44 is another level in focus going into the close.

Stock Market Today

  • Nasdaq Chipmakers Rally as OpenAI Files for IPO Amid Market Rebound
    June 9, 2026, 9:47 AM EDT. Nasdaq chipmakers led Wall Street's rebound after last week's tech sell-off, with Nvidia, AMD, Micron, and Broadcom recovering losses. Futures rose ahead of key US inflation data due Wednesday and Thursday, which investors see as crucial for Federal Reserve's interest rate outlook. Oil prices eased below $90 a barrel, easing inflation worries and supporting risk appetite. Asian markets rallied, notably Seoul's Kospi up 8.2%, while European markets were mixed. In company news, OpenAI filed confidentially for an IPO, eyeing an autumn listing, following anticipated floats from SpaceX and Anthropic. US small business optimism slipped in May, missing forecasts, but economists noted survey limitations.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Caterpillar stock jumps 4% as Wolfe lifts target to $670; investors brace for Jan. 9 jobs report
Previous Story

Caterpillar stock jumps 4% as Wolfe lifts target to $670; investors brace for Jan. 9 jobs report

Broadcom stock today: AVGO holds gains after hours as CFO sale notice and chip rally grab attention
Next Story

Broadcom stock today: AVGO holds gains after hours as CFO sale notice and chip rally grab attention

Go toTop